These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6093280

  • 1. The increased sensitivity of platelets to prostacyclin in marathon runners.
    Dix CJ, Hassall DG, Bruckdorfer KR.
    Thromb Haemost; 1984 Jul 29; 51(3):385-7. PubMed ID: 6093280
    [Abstract] [Full Text] [Related]

  • 2. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
    Vanderwel M, Haslam RJ.
    J Clin Invest; 1985 Jul 29; 76(1):233-40. PubMed ID: 2991338
    [Abstract] [Full Text] [Related]

  • 3. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov 29; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 4. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L, Tijhuis D, Wessels H, Haanen C.
    Thromb Haemost; 1981 Apr 30; 45(2):142-5. PubMed ID: 6266068
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
    Siegl AM, Daly JW, Smith JB.
    Mol Pharmacol; 1982 May 30; 21(3):680-7. PubMed ID: 6287202
    [No Abstract] [Full Text] [Related]

  • 6. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
    Siegl AM, Daly JW.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 May 30; 10(3):229-45. PubMed ID: 2991349
    [Abstract] [Full Text] [Related]

  • 7. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU, Standl E, Mehnert H.
    Horm Metab Res Suppl; 1981 May 30; 11():26-9. PubMed ID: 6172351
    [Abstract] [Full Text] [Related]

  • 8. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M, Zahavi J, Kakkar VV.
    Thromb Haemost; 1984 Oct 31; 52(2):205-9. PubMed ID: 6098048
    [Abstract] [Full Text] [Related]

  • 9. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
    Dembinska-Kiec A, Rücker W, Schönhöfer PS, Gandolfi C.
    Thromb Haemost; 1979 Dec 21; 42(4):1340-3. PubMed ID: 232318
    [No Abstract] [Full Text] [Related]

  • 10. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.
    Bruckdorfer KR, Buckley S, Hassall DG.
    Biochem J; 1984 Oct 01; 223(1):189-96. PubMed ID: 6093767
    [Abstract] [Full Text] [Related]

  • 11. Drug stimulated prostacyclin release.
    Weithmann KU.
    Ric Clin Lab; 1981 Oct 01; 11 Suppl 1():209-14. PubMed ID: 6324324
    [Abstract] [Full Text] [Related]

  • 12. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS, Kwok CF, Wong MC, Chiang H.
    Diabetes Res; 1994 Oct 01; 27(1):39-46. PubMed ID: 7648795
    [Abstract] [Full Text] [Related]

  • 13. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD, Knudsen F, Nielsen AH, Ring T.
    Clin Nephrol; 1984 Apr 01; 21(4):230-4. PubMed ID: 6375926
    [Abstract] [Full Text] [Related]

  • 14. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
    Wilson NH, Armstrong RA, Jones RL.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Apr 01; 17A():491-5. PubMed ID: 2821762
    [No Abstract] [Full Text] [Related]

  • 15. [Mechanisms of changes in the sensitivity of platelets to prostacyclin in patients with cerebrovascular diseases].
    Akopov SE, Mkhitarian GS, Nikogosian GA, Gabrielian ES.
    Vopr Med Khim; 1988 Apr 01; 34(6):46-9. PubMed ID: 2853489
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 17. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K, Faul C, Daiss W, Weisenberger H.
    Prostaglandins Leukot Med; 1986 Oct 29; 24(2-3):199-206. PubMed ID: 2432618
    [Abstract] [Full Text] [Related]

  • 18. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP, Sushkevich GN, Lukoianova TI.
    Patol Fiziol Eksp Ter; 1980 Oct 29; (4):80-5. PubMed ID: 6251418
    [No Abstract] [Full Text] [Related]

  • 19. [The adenylate cyclase system of human platelets].
    Ferry N, Adnot S, Insel PA, Hanoune J.
    Nouv Rev Fr Hematol (1978); 1983 Oct 29; 25(6):343-53. PubMed ID: 6141550
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T, Satoh K, Nishimura T, Horikawa N, Mine T, Hirohashi T, Hara Y.
    Arzneimittelforschung; 1994 Apr 29; 44(4):483-90. PubMed ID: 8011001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.